Starting in June, the familiar sights of anxious parents standing in long lines at pharmacies every month are expected to be significantly reduced. An amendment to the Dangerous Drugs Regulations, which will officially come into effect in June 2026, will grant physicians the long-awaited authority to instruct the dispensing of two prescriptions for attention and concentration medications simultaneously, instead of the single prescription that has been customary until now.
The move, which has received the support of many professional bodies, seeks to correct a longstanding bureaucratic injustice that has harmed patients’ quality of life and consumed the time of physicians and pharmacists alike.
An end to the “8-day chase”
Until now, the reality for patients with attention deficit hyperactivity disorder (ADHD) has…